24 May 2013
Keywords: citicoline, cuts, disability, after, ischemic, stroke, interneuron
Article | 22 April 1996
Interneuron has reported final Phase III trial results which show that its citicoline drug reduces disability by as much as 50% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.